Fastinov

Biotechnology
EGF II | EGF III | EGF IV

Invested In

2022

Divested In

–

Investment Rationale

Development of differentiating technology to fight against antimicrobial resistance.

Strategy

Support solution development and go-to-market strategy
Company website
FASTINOV
arrow_b Back to Portfolio

Explorer Investments
Largo Jean Monnet, nº 1 – 8º
1269-068 Lisboa, Portugal

Invest with us:

arrow_b André Bandeira

Partner with us:

BUYOUTS

arrow_b Pedro Coutinho

GROWTH

arrow_b António Rocha e Silva

HOSPITALITY

arrow_b José Tiago Silva

Hospitality investments

arrow_b Massimo Massimilla

Associations and Memberships

invest_europe
pri
apcr
bcsd
cmvm
Terms and conditions
Privacy policy
Cookie policy

Design by:

Developed by:

Coeos Digital, Lda